As the opioid crisis continues to grip the United States—fueled in large part by the proliferation of fentanyl—effective and evidence-based treatment options are more...
Over the past decade, the healthcare industry has seen a slow but steady shift toward value-based care models in various sectors. However, in addiction...
Eric Frieman’s entry into the world of behavioral health care, mental health, and substance use treatment was deeply personal, sparked by the devastating loss...
In recent years, mergers and acquisitions (M&A) within the substance use disorder (SUD) treatment space have been relatively slow. However, with the anticipated shift...
As mental health climbs the list of top concerns for today’s workforce, a recent Mercer report highlights a surprising gap: while many employers are...
Weight-loss medications like Ozempic and Wegovy, which were originally developed for the treatment of diabetes, have become a sensation in recent years as effective...